Resources Library by ANA

Lessons from consumer marketing

The author of this paper covers some of the requirements for producing great consumer advertising and assesses some of the implications for pharmaceutical marketing. The scope is the strategy behind great advertising. Excellent implementation is...

Catalogue: ESOMAR Global Healthcare 2002

Author: Sharon Spiers

February 17, 2002

Why DTC advertising has failed in the United States and how it can succeed

Since restrictions on direct-to-consumer (DTC) advertising were loosened in 1997, spending on DTC advertising in the United States has quadrupled. Now the European Union may soon begin testing DTC advertising, but not much consumer research on DTC...

Catalogue: ESOMAR Global Healthcare 2002

Authors: Michelle Castillo, Renee Hopkins

Company: Decision Analyst, Inc.

February 17, 2002

Recognizing the role of the consumer in pharmaceutical research

Greater access to information has allowed people to be more involved in their healthcare to the point where many health conditions can now be viewed as quasi-consumer markets. This creates a new landscape for marketers where customization is the key...

Catalogue: ESOMAR Congress 2001: Marketing Transformation

Authors: Sharon Spiers, Mark Blakely

September 23, 2001

eBusiness changes global and strategic marketing

This paper provides a comprehensive description and definition of the eBusiness landscape, how it affects healthcare, and opportunities created in the health industry and specifically in diabetes care. Marketing and sales managers are bombarded with...

Catalogue: ESOMAR Global Healthcare 2001: Changes In Competitive Dynamics

Author: Meinhard F. Schmidt

Company: Roche

May 1, 2001

Knowing the future

Using data collected in the springs of 1999 and 2000 from a standardized survey of over 18,000 respondents across the United States, a prospective model of health plan customer loyalty was developed. The model was based on a combination of...

Catalogue: ESOMAR Global Healthcare 2001: Changes In Competitive Dynamics

Author: James Bologna

April 1, 2001

Global healthcare

The pharmaceutical and medical instruments industries have become global industries. The industries have evolved from a group of independent affiliates to virtual organizations with locations all over the world. At the same time there is a booming...

Catalogue: ESOMAR Global Healthcare 2001: Changes In Competitive Dynamics

Author: Dirk Huisman

April 1, 2001

Mergers and acquisition

The purpose of this paper is to analyse the mergers and acquisitions that have taken place in the Indian pharmaceutical industry, and develop a framework, which would provide directions for a successful merger. In the context of a spurt in the number...

Catalogue: ESOMAR Global Healthcare 2001: Changes In Competitive Dynamics

Authors: Suday Karkera, Trilochan Raval

April 1, 2001

Strategic market segmentation

Previous work by Maclennan and Mackenzie indicated that while top executives in the pharmaceutical industry often advocate being market oriented and customer focused, few companies (large or small) use market segmentation to its maximum potential....

Catalogue: ESOMAR Global Healthcare 2001: Changes In Competitive Dynamics

Authors: David Mackenzie, Cathy Clerinx

April 1, 2001

Speed, power and efficiency

This paper presents a case study involving a leading pharmaceutical information company that uses internet-based research as a means of gathering primary data from physicians and other subjects. The company, MORPACE Pharma Group, is now moving toward...

Catalogue: ESOMAR Net Effects 2001

Authors: Karen J. Partridge, Allen Kamer

February 11, 2001